Katie King, co-founder and chief executive of BioOrbit, discusses how her company is building pharmaceutical manufacturing facilities designed to operate in space and why that could fundamentally transform how the production of medicine works.
BioOrbit is a British space tech company that aims to use the irreplicable conditions of outer space to improve the development of drugs that could massively shape how humans treat some of Earth’s most dangerous conditions.
Listen to the full episode here, along with all previous episodes of the UKTN Podcast.
Sign up for our podcast newsletter to ensure you don’t miss an episode.
You’re not ordinary. No 9 to 5, meetings about meetings or compulsory corporate team building for you.
Your business is extraordinary, and you need an extraordinary bank.
From pre-seed to IPO and beyond, HSBC Innovation Banking offers VC-backed tech and life science businesses custom solutions, co-created by actual industry experts and delivered by a dedicated team you can call whenever you need.
Discover extraordinary at hsbcinnovationbanking.com/gb/en.